Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Bono

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2008
Reovirus: viral therapy for cancer 'as nature intended'C Comins, L Heinemann, K Harrington, et al.
British Journal of Cancer|March 20, 2008
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experienceH-T Arkenau, D Olmos, J E Ang, et al.
Gynecologic Oncology|October 27, 2006
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer centerF Legge, D Eaton, R Molife, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate CancerM Wilbaux, M Tod, J De Bono, et al.
British Journal of Anaesthesia|April 26, 2007
Coronary artery stents and non-cardiac surgeryG M Howard-Alpe, J de Bono, L Hudsmith, et al.
ESMO Open|June 18, 2025
Blood tumor load: combining biomarkers to increase the proportion of informative patientsE Dathathri, A Nanou, F-C Bidard, et al.
Brain Research Bulletin|January 1, 1996
FosB in the suprachiasmatic nucleus of the Syrian and Siberian hamsterF J Ebling, E S Maywood, M Mehta, et al.
ESMO Open|March 19, 2021
An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancerA Thiery-Vuillemin, K Fizazi, O Sartor, et al.
British Journal of Cancer|April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2008
Reovirus: viral therapy for cancer 'as nature intended'C Comins, L Heinemann, K Harrington, et al.
British Journal of Cancer|March 20, 2008
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experienceH-T Arkenau, D Olmos, J E Ang, et al.
Gynecologic Oncology|October 27, 2006
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer centerF Legge, D Eaton, R Molife, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate CancerM Wilbaux, M Tod, J De Bono, et al.
British Journal of Anaesthesia|April 26, 2007
Coronary artery stents and non-cardiac surgeryG M Howard-Alpe, J de Bono, L Hudsmith, et al.
ESMO Open|June 18, 2025
Blood tumor load: combining biomarkers to increase the proportion of informative patientsE Dathathri, A Nanou, F-C Bidard, et al.
Brain Research Bulletin|January 1, 1996
FosB in the suprachiasmatic nucleus of the Syrian and Siberian hamsterF J Ebling, E S Maywood, M Mehta, et al.
ESMO Open|March 19, 2021
An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancerA Thiery-Vuillemin, K Fizazi, O Sartor, et al.
British Journal of Cancer|April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.
Pageof 5